Drug Trial Radar · NCT00000914
A Study of the Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 Weeks
Last checked: Nov 19, 2026Latest source record: Oct 29, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
800
Actual
Start
Not stated
Primary completion
Not stated
Study completion Jun 2000
Sponsor
- Sponsor type
- NIH
- First posted
- Aug 31, 2001
Design
- Study type
- Interventional
- Phase
- Not applicable
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare different treatments for HIV infection to see which works best to lower HIV levels and to raise the number of CD4 cells (cells of the immune system that fight infection), in HIV-positive individuals who have been on a protease inhibitor-containing drug regimen for at least 16 weeks. Researchers have found that combination anti-HIV therapy (multiple drugs given together) can help prevent AIDS-related illnesses and help people with AIDS live longer. In this study, the anti-HIV drug efavirenz (EFV) will be tested with 1 or 2 other protease inhibitors (PIs) to see which combination works best to treat HIV infection. EFV has been shown to limit the amount of HIV virus produced by infected cells.
Conditions
- HIV Infections
Interventions
Indinavir sulfateDrug
RitonavirDrug
Nelfinavir mesylateDrug
EfavirenzDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
Community Consortium / UCSF
San Francisco, California
Denver CPCRA / Denver Public Hlth
Denver, Colorado
Washington Reg AIDS Prog / Dept of Infect Dis
Washington D.C., District of Columbia
AIDS Research Consortium of Atlanta
Atlanta, Georgia
AIDS Research Alliance - Chicago
Chicago, Illinois
Louisiana Comm AIDS Rsch Prog / Tulane Univ Med
New Orleans, Louisiana
Wayne State Univ - WSU/DMC / Univ Hlth Ctr
Detroit, Michigan
Henry Ford Hosp
Detroit, Michigan
Southern New Jersey AIDS Cln Trials / Dept of Med
Camden, New Jersey
North Jersey Community Research Initiative
Newark, New Jersey
Partners in Research / New Mexico
Albuquerque, New Mexico
Harlem AIDS Treatment Grp / Harlem Hosp Ctr
New York, New York
The Research and Education Group
Portland, Oregon
Philadelphia FIGHT
Philadelphia, Pennsylvania
Richmond AIDS Consortium / Div of Infect Diseases
Richmond, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.